Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Gan & Lee

Gan & Lee Pharmaceutical (603087): 2021 Annual General Meeting of Shareholders CFi.CN

  • Post date May 13, 2022 — 21:23 Post Lock Login to View

Read More

[China Securities Pre-market] The first-quarter net profit of "Chip One Brother" increased by more than 175%! Tenlian Board Xinhua Pharma Employee Stock Ownership Plan Clearance; Philips Plans to Transfer 10% of Entrepreneurship Huikang

  • Post date May 13, 2022 — 09:48 Post Lock Login to View

Read More

Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval.

  • Post date May 12, 2022 — 20:59 Post Lock Login to View

Read More

On the evening of May 12th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

  • Post date May 12, 2022 — 19:50 Post Lock Login to View

Read More

Can insulin "price-for-volume" bring new revenue? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points.

  • Post date May 1, 2022 — 00:19 Post Lock Login to View

Read More

The truth in the financial report: Can the "price-for-volume" of insulin in the pharmaceutical industry bring about new revenue growth? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points.

  • Post date May 1, 2022 — 00:16 Post Lock Login to View

Read More

Can insulin "price-for-volume" bring new revenue? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points_Oriental Fortune Net

  • Post date April 30, 2022 — 22:19 Post Lock Login to View

Read More

The truth in the financial report: Can the "price-for-volume" of insulin in the pharmaceutical industry bring about new revenue growth? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points.

  • Post date April 30, 2022 — 22:16 Post Lock Login to View

Read More

The truth in the financial report: Can the "price-for-volume" of insulin in the pharmaceutical industry bring about new revenue growth? Before the answer was announced, Gan & Lee Pharmaceutical went overseas to find new profit growth points

  • Post date April 30, 2022 — 22:16 Post Lock Login to View

Read More

Gan & Lee Pharmaceutical's 2021 revenue and net profit double increase, rapid expansion of production capacity, layout in domestic and overseas markets

  • Post date April 28, 2022 — 11:26 Post Lock Login to View

Read More

Investment hedging guide: Global smartphone AMOLED panel shipments fell by 8% year-on-year in the first quarter, the Economic Daily said that driving up coal prices must be cracked down, and Cinda Real Estate’s first-quarter net profit fell by 89.73% year-on-year

  • Post date April 28, 2022 — 08:39 Post Lock Login to View

Read More

Gan & Lee Pharmaceutical (603087.SH) released its 2021 results, with a net profit of 1.453 billion yuan, a year-on-year increase of 18.04%, and 3 yuan for every 10 shares.

  • Post date April 27, 2022 — 22:07 Post Lock Login to View

Read More

Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out?

  • Post date April 21, 2022 — 09:05 Post Lock Login to View

Read More

What are the leading stocks in the pharmaceutical industry?

  • Post date April 19, 2022 — 17:05 Post Lock Login to View

Read More

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina

  • Post date April 19, 2022 — 07:36 Post Lock Login to View

Read More

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG_Individual Stock Information_Market Gold Online

  • Post date April 19, 2022 — 07:31 Post Lock Login to View

Read More

Qiming Venture Partners Liang Yingyu and Kwong Ziping Named the Best Global Venture Capitalists in Forbes Midas List in 2022

  • Post date April 13, 2022 — 14:10 Post Lock Login to View

Read More

Qiming Venture Partners Liang Yingyu and Kwong Ziping Named the Best Global Venture Capitalists in Forbes Midas List in 2022

  • Post date April 13, 2022 — 13:24 Post Lock Login to View

Read More

Qiming Venture Partners Liang Yingyu and Kwong Ziping named 2022 Forbes Best Global Venture Capitalists

  • Post date April 13, 2022 — 12:16 Post Lock Login to View

Read More

Gan & Lee Pharmaceutical: It has been confirmed that the company's subsidiary Ndogenikos in Russia is operating and producing normally jqknews

  • Post date April 7, 2022 — 19:53 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.